Stock listing

Towa Pharmaceutical Co., Ltd.

Selected listing: 6QC · DUS · EUR · DE

Towa Pharmaceutical Co., Ltd. (Dusseldorf:6QC), Health Technology. Latest release Sep 2, 2026: Towa Pharmaceutical : FY2026(1st quarter) Briefing Script…

6QC:DUSEURDEUpdated September 26, 2026

Ticker: Dusseldorf:6QC
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Towa Pharmaceutical Co., Ltd.

Towa Pharmaceutical : FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)

September 1, 2026

Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)

August 6, 2026

Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment

July 31, 2026

Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

July 10, 2026

Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals

July 3, 2026

All Towa Pharmaceutical Co., Ltd. news →

Research Towa Pharmaceutical Co., Ltd.

Towa Pharmaceutical Co., Ltd. company profile

View the public company page for Towa Pharmaceutical Co., Ltd. on 6ix.

Towa Pharmaceutical Co., Ltd. news

Read company news and market updates connected to Towa Pharmaceutical Co., Ltd..

Towa Pharmaceutical Co., Ltd. investor events

Find investor webinars, events, and replay context for Towa Pharmaceutical Co., Ltd..